Patterson Companies, Inc. (NASDAQ:PDCO) Shares Bought by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans increased its holdings in Patterson Companies, Inc. (NASDAQ:PDCO - Free Report) by 18.9% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 73,462 shares of the company's stock after buying an additional 11,698 shares during the period. Thrivent Financial for Lutherans owned about 0.08% of Patterson Companies worth $2,143,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Harbour Investments Inc. bought a new position in shares of Patterson Companies in the 4th quarter worth $26,000. GAMMA Investing LLC raised its holdings in Patterson Companies by 103.0% in the fourth quarter. GAMMA Investing LLC now owns 1,340 shares of the company's stock worth $41,000 after purchasing an additional 680 shares in the last quarter. Anchor Investment Management LLC lifted its position in shares of Patterson Companies by 20.5% during the third quarter. Anchor Investment Management LLC now owns 2,350 shares of the company's stock valued at $51,000 after buying an additional 400 shares during the last quarter. Wilmington Savings Fund Society FSB bought a new stake in shares of Patterson Companies in the 3rd quarter valued at about $65,000. Finally, Blue Trust Inc. grew its position in shares of Patterson Companies by 18.0% in the 4th quarter. Blue Trust Inc. now owns 2,738 shares of the company's stock worth $84,000 after buying an additional 417 shares during the last quarter. Hedge funds and other institutional investors own 85.43% of the company's stock.

Patterson Companies Stock Performance

Shares of NASDAQ:PDCO traded up $0.02 during trading on Wednesday, hitting $31.28. The stock had a trading volume of 714,937 shares, compared to its average volume of 1,057,670. The company has a quick ratio of 0.76, a current ratio of 1.37 and a debt-to-equity ratio of 0.34. Patterson Companies, Inc. has a 12-month low of $19.45 and a 12-month high of $31.79. The stock has a market capitalization of $2.77 billion, a price-to-earnings ratio of 18.29, a price-to-earnings-growth ratio of 2.71 and a beta of 0.99. The stock has a 50-day simple moving average of $31.10 and a two-hundred day simple moving average of $26.77.

Remove Ads

Analyst Upgrades and Downgrades

A number of research firms recently commented on PDCO. Stifel Nicolaus decreased their target price on shares of Patterson Companies from $25.00 to $24.00 and set a "hold" rating for the company in a research report on Thursday, December 5th. Piper Sandler lowered their price objective on Patterson Companies from $26.00 to $24.00 and set a "neutral" rating for the company in a research report on Friday, December 6th. StockNews.com assumed coverage on Patterson Companies in a research note on Thursday, March 27th. They set a "hold" rating on the stock. Leerink Partners reissued a "market perform" rating and issued a $31.35 price target (up previously from $29.00) on shares of Patterson Companies in a report on Wednesday, December 11th. Finally, Morgan Stanley upped their price objective on shares of Patterson Companies from $27.00 to $31.35 and gave the company an "equal weight" rating in a report on Tuesday, December 17th. Eleven research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $26.57.

Patterson Companies Company Profile

Patterson Companies, Inc engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.